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Abstract
The binding of zinc to human K-fetoprotein (AFP) isolated from human umbilical cord serum was studied by fluorimetric
Zn2-titration. We found that the total number of strong binding sites for zinc on this protein was 5: AFP has one very
strong (dissociation constant, Kd6 1038 M) and at least four lower affinity zinc binding sites (Kd6 1035 M). Fourier
transform infrared (FTIR) analysis revealed that aspartate and histidine residues could be involved in the strong
coordination of zinc. Intriguingly, binding of zinc to the protein does not induce structural changes that can be detected by
circular dichroism, FTIR, intrinsic fluorescence or (1,1P)-bi-(4-anilino)naphthalene-5,5P-disulfonic acid (bis-ANS) binding.
Finally, scanning microcalorimetry measurements showed that stability of the protein is also unaffected by zinc binding in
spite of the strength of the coordination. Such strong interactions without major structural consequences are highly unusual,
and AFP may therefore be the first characterized representative of a new class of ligand-binding proteins. ß 2002 Elsevier
Science B.V. All rights reserved.
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1. Introduction
K-Fetoprotein (AFP) is an oncofetal glycoprotein
consisting of 590 amino acid residues [1] that is pro-
duced primarily by fetal liver and yolk sack cells.
AFP levels correlate with fetal maturity, being very
high during embryo development and decreasing
abruptly just after birth. An increase in the AFP
content in adult sera is evidence of the development
of several disorders [2].
AFP is a well-known molecular marker indicating
either the development of cancer or fetal abnormal-
ities [2^9]. In addition to its substantial diagnostic
importance, the physiological functions of AFP are
also of great interest. It has been established that
AFP isolated from amniotic £uid or the fetal sera
of rats is capable of binding estrogens [9^12]. It
was shown that AFP strongly binds to fatty acids
[9,13,14] ^ material isolated from human fetuses con-
tains from 2^3 molecules of fatty acid per protein
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molecule, (mainly unsaturated: arachidonic ^ C20:4
^ and docosahexaenoic ^ C22:6 ^ acids). Human
hepatoma AFP isolates have a much larger variety
of bound fatty acid than fetal isolates [13,15]. A sin-
gle high-a⁄nity binding site for bilirubin has also
been demonstrated [14,16]. In addition to its trans-
port function, AFP plays a role in the regulation of
cell division and metabolism and modulates the be-
havior of microphages [17] and T-lymphocytes [18].
A role for AFP in the suppression of the immune
response has also been suggested [9,17,19].
It is known that AFP and human serum albumin
(HSA) have considerable structural similarity
[1,21,22,26,27] and interact with the same organic
ligands; for this reason AFP is often regarded as a
fetal-type albumin [9]. There are, however, di¡eren-
ces between the binding properties of these two pro-
teins ^ the number of di¡erent ligands transported by
HSA is much larger than that of AFP. Additionally,
albumin’s a⁄nity for many organic ligands is in the
range of dissociation constant Kd = 1036^1034 M,
while for AFP the binding is considerably stronger
(Kd = 1038^1036 M) [9]. Natural ligands play an im-
portant role in stabilizing the native tertiary structure
of AFP [20^25]. The complete removal all ligands
transforms AFP into a molten globule-like confor-
mation [21^23]. In contrast, release of ligands from
HSA causes only a minor decrease in its stability
[21,28].
Although for HSA the formation of stable com-
plexes with Ca2 [29] ; Cu2 and Ni2 [30,31]; Zn2
[32] ; Mg2, Co2 and Cd2 [33] and many other
metal cations has been established [34], little is cur-
rently known about the interaction of AFP with met-
al ions. The presence of high-a⁄nity binding sites for
copper and nickel on human AFP has been observed
[35], and its interaction with several heavy metals
(including zinc and lead) has been studied by gel-
¢ltration chromatography [36]. This method is
known to give reasonable estimates of the dissocia-
tion constants in the micromolar range. AFP was
shown to be capable of binding to a total of V16
Zn2 ions. Of these, 4^5 bind to high-a⁄nity sites
with dissociation constants on the order of Kd = 6^
8U1036 M [36]. The Kd estimates for low-a⁄nity
sites were less certain, and the structural e¡ects of
zinc binding to AFP were not explored.
Zinc is essential for the normal function of most
organisms and it has been shown to be a required
cofactor in a variety of biochemical processes in
plants, bacteria and higher organisms [37^39].
Zinc is particularly important for fetal growth in
vertebrates [39]. The concentration of this metal in
living cells is high ^ it is second only to iron among
the transition elements. It is therefore not surpris-
ing that Zn2 de¢ciency causes several pathological
disorders [39]. Zinc ions are key structural compo-
nents in a large number of proteins, and are essen-
tial for catalytic activity. The list of zinc-binding
and zinc-activated proteins includes, for example,
DNA and RNA polymerases, carboxypeptidases,
alcohol dehydrogenase, phospholipases and many
others [39].
In the following paragraphs we present the results
of a spectroscopic study that characterizes the struc-
ture of human AFP and its interaction with Zn2.
The primary Zn2 titration data are based on cation-
induced changes in protein £uorescence parameters.
This approach allows precise measurements within a
wide range of dissociation constant values. To sup-
plement this data, we present circular dichroism
(CD), Fourier transform infrared (FTIR), calorimet-
ric and £uorescence data that characterize the e¡ect
of zinc on the secondary and tertiary structure of
AFP as well as its stability, solvent accessibility
and hydrophobicity.
2. Materials and methods
2.1. Protein isolation
The protein was isolated from human umbilical
cord serum by chromatographic and immunoa⁄nity
methods. The major contaminant proteins were re-
moved by a series of chromatographic steps includ-
ing DEAE^Sephadex, DEAE^Sepharose, KM^Se-
pharose, Cibacron Blue^Sepharose and protein G^
Sepharose columns. The ¢nal stages of AFP puri¢-
cation were carried out on immunoa⁄nity columns
with immunosorbents saturated with antibodies
against impurity proteins. The purity of AFP was
no less than 98%, as measured by sodium dodecyl
sulfate and native polyacrylamide gel electrophoresis.
Apo-form of AFP was prepared according to Blum
et al. [40].
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2.2. Materials
Bu¡er compounds and analytical or extra pure
grade urea were used without additional puri¢cation.
Zinc-titration experiments were performed in 10 mM
HEPES bu¡er, pH 8.0. Calorimetric measurements
were carried out in 50 mM cacodylate bu¡er, pH
6.88. The bu¡er system for FTIR and CD measure-
ments was 100 mM sodium phosphate, 0.15 M NaCl,
pH 7.2.
2.3. Spectroscopic measurements
Protein concentrations were determined by the ab-
sorbance at 280 nm using extinction coe⁄cient of
O1 mg=ml1 cm; 280 nm and 0.455 for AFP and bovine serum albu-
min (BSA), respectively. For circular dichroism (CD),
infrared and calorimetric measurements the protein
concentration was 0.5^1.0 mg/ml, while £uorescence
measurements used 0.01 mg/ml protein solutions.
CD spectra were collected on an AVIV-60DS spec-
tropolarimeter, equipped with a temperature-con-
trolled cell-holder. The cell path lengths were 0.1
and 10.0 mm for far and near UV CD measurements,
respectively. Trp and (1,1P)-bi-(4-anilino)naphthalene-
5,5P-disulfonic acid (bis-ANS) £uorescence were mea-
sured with a Jobin Yvon-Spex FluoroMax-2 £uorim-
eter with excitation at 296 or 350 nm, respectively.
Acrylamide quenching studies were performed by
adding aliquots from a stock acrylamide solution to
a cuvette containing protein solution. Fluorescence
intensities were corrected for dilution e¡ects. Fluores-
cence quenching data were analyzed using the general
form of the Stern^Volmer equation, which explicitly
models both dynamic and static quenching [41] :
I0
I
 1 KSVQeV Q
where I0 and I are the £uorescence intensities in the
absence and presence of quencher, respectively; KSV
is the dynamic quenching constant; V is a static
quenching constant; [Q] is the concentration of the
quencher.
2.4. Attenuated total re£ection (ATR)-FTIR spectra
ATR-FTIR spectra were collected on an air-
purged Nicolet 800SX spectrometer equipped with
an N2(l)-cooled MCT detector [42]. Sample solutions
were applied to the surface of a 72U10U6 mm, 45‡
trapezoidal germanium internal re£ection element
(IRE), and the bulk solvent was evaporated under a
gentle stream of nitrogen gas. One hudred and
twenty-eight scans were accumulated for each sample
at a resolution of 4 cm31. Interferograms were trans-
ferred to a Windows PC, and processed with
GRAMS/32 (Galactic Industries) and the SAFAIR
software package (America’s Solutions Providers, Or-
lando, FL). Fourier transformation used the Mertz
method with medium Norton^Beer apodization. Ab-
sorbance spectra were generated using the spectrum
of the clean IRE as a reference. Water vapor signal
was subtracted based on the area of the 1712 peak
during the generation of absorbance spectra. Minor
imprecision in this subtraction was corrected during
the optimization of subsequent subtraction steps by
simultaneous vapor-subtraction. Secondary structure
determination was performed using a partial least-
squares analysis (PLSPlus for GRAMS/32) with the
RaSP50 protein reference set [43,44]. For the analy-
ses, IR and CD data were combined into a single
‘hybrid’ spectrum (K.A. Oberg, J.M. Ruysschaert,
E. Goormaghtigh, unpublished data).
K-Fetoprotein samples were 80 Wl of 1 mg/ml so-
lution in 1 mM HEPES bu¡er (pH 8.0) with or with-
out a 10-fold molar excess of zinc (ZnCl2). Bovine
serum albumin (Sigma B1900) was prepared as a 10
mg/ml solution in ddH2O (150 WM); 20 Wl was ap-
plied to the IRE surface for each sample, with or
without a 13-fold molar excess of zinc (a 130-fold
excess was examined also). Amino acid solutions of
glycine, aspartic acid, glutamic acid, and histidine
HCl (Sigma) were prepared by dissolving each com-
pound in water to a ¢nal concentration of 100 mM;
one equivalent of NaOH was added to each solution
except glycine. These solutions were then diluted into
¢ve volumes of ddH2O or 100 mM zinc chloride; 20
Wl of this ¢nal solution was used to prepare a thin
¢lm for ATR in the manner described above. Finally,
two spectra of zinc chloride were collected under
atmospheres with di¡erent water vapor content.
There is evidence of a substantial amount of
bound water in the ATR-FTIR spectrum of a zinc
chloride thin ¢lm (Fig. 5). Bands at 3425, 2006, and
1619 cm31 show the intensity pattern characteristic
of water, but with o¡set frequencies, which is indica-
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tive of substantial interaction with the hygroscopic
salt. By using a large excess of zinc chloride in
each of the ATR ¢lms, conditions were such that
this signal and any other characteristics of zinc chlo-
ride dominated the spectrum and could therefore be
removed by subtraction of the pure ZnCl2 ¢lm spec-
trum. Extraction of amino acid spectra was per-
formed by iteratively optimizing a subtraction scaling
factor to give a linear baseline in the 1900^1700 cm31
region with the SAFAIR ‘linear’ function. This ap-
proach removed the hydrated ZnCl2 signal from the
total spectrum without over subtracting.
2.5. Calorimetric measurements
Calorimetric measurements were made with a
DASM-4M scanning microcalorimeter (Institute for
Biological Instrumentation of the Russian Academy
of Sciences, Pushchino, Moscow Region, Russia).
The rate of heating was 1 K/min. The excess pressure
was kept at 3.6 atm. The excess heat capacity of AFP
was determined as described elsewhere [45].
3. Results
3.1. The secondary structure of AFP and SA
Fig. 1 compares far UV CD and FTIR spectra of
two homologous proteins, AFP and BSA. The far
UV CD spectrum of HSA is also present for com-
parison. One can see that HSA and BSA have com-
pletely superimposable spectra, re£ecting the essen-
tially identical structure of these proteins. Fig. 1A
demonstrates also that far UV CD spectrum of
AFP is very di¡erent from spectra of both serum
albumins. However, Fig. 1B shows that the IR spec-
tra of AFP and BSA have a similar appearance, with
sharp symmetrical peaks at 1656 and 1545 cm31
which are characteristic of all-K proteins. The results
of quantitative secondary structure analyses of the
spectra with the RaSP50 reference set [43,44] are
shown in Table 1. Analysis of hybrid IR-CD spec-
trum ([46]; K.A. Oberg, J.M. Ruysschaert, E. Goor-
maghtigh, unpublished data) allows us to estimate
that the helix content is in fact, quite high for
AFP, being comparable to the globins or 4-helix
bundle proteins [44].
3.2. Spectro£uorimetric titration of AFP with Zn2+
The £uorescence results from Zn2-titration of
AFP are shown in Fig. 2A. The increase in Zn2
concentration results in a small blue shift of the in-
trinsic tryptophan £uorescence spectrum and a de-
crease in £uorescence quantum yield (see inset to
Fig. 2A). Fig. 2A shows that the spectral changes
proceed in two distinct steps. The ¢rst stage corre-
Fig. 1. Far UV CD (A) and FTIR (B) spectra of AFP (solid line) and BSA (dashed line) measured under conditions of 100 mM so-
dium phosphate bu¡er (pH 7.2), 0.15 M NaCl. Far UV CD spectrum of HSA is shown for comparison (dotted line). The protein
concentration was 0.5 and 1.0 mg/ml for CD and FTIR measurements, respectively. Cell with pathlength of 0.1 mm was used in far
UV CD spectra measurements.
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sponds to the strong binding of one Zn2 per protein
molecule, while the second step is due to the coop-
erative binding of several additional Zn2 ions to the
zinc-loaded protein (Scheme 1):
Protein Zn2Ik1 Protein Zn
Protein Zn nZn2Ik2 Protein Znn1
Scheme 1
The Zn2-induced changes in Trp £uorescence in-
tensity were ¢t according to the Scheme 1. The ¢t
was optimized by varying the number of zinc cations
bound, n, and the binding constant values k1 and k2.
The best ¢t was achieved when k1 = 1.0U109 M31,
k2 = 1.1U105 M31 and n = 4.1. Interestingly, Fig. 2A
shows that the titration results are independent of
the nature of anion (Cl3 or SO234 ) assuming that
the observed e¡ects are de¢nitely due to the Zn2
binding.
Similar results were obtained when zinc-AFP bind-
ing was monitored by changes in bis-ANS £uores-
cence (Fig. 2B), which shows that increasing the
Zn2 concentration caused a blue shift of the bis-
ANS £uorescence spectrum maximum and an in-
crease in its intensity. It can also be seen that bis-
ANS £uorescence is a¡ected by the binding of Zn2
to both the strong site and the weaker secondary
sites, although binding to the strong site produces a
much smaller change in £uorescence. Fits of the £uo-
rescence intensity at 440 nm gave k1V1U109 M31,
k2 = 1.1U105 M31 and n = 2.5. Note that these esti-
mates of the binding parameters, based on the prop-
erties of an extrinsic probe, agree well with the pa-
rameters determined using the intrinsic £uorescence
of AFP.
The very tight association of zinc with AFP
brought up the question of possible structural con-
sequences of the interaction. It is known that natural
ligands often play an important role in stabilizing
protein structure [47]. It has been demonstrated
that complete release of organic ligands transforms
AFP into a molten globule-like conformation, i.e., a
compact denatured form, with native-like compact-
ness and secondary structure content but the absence
of rigid tertiary structure [21^23].
3.3. E¡ect of zinc binding on structural properties of
AFP
The data presented in the inset to Fig. 2A are
consistent with the suggestion that the interaction
of AFP with zinc induces some changes in the en-
vironment of tryptophan. To further probe such
changes we investigated the acrylamide quenching
of Trp £uorescence. Fig. 3 shows the upward curva-
ture of the Stern^Volmer plots obtained from these
measurements; this is characteristic of both dynamic
and static quenching. The data were analyzed ac-
cording to the general form of the Stern-Volmer
equation (see Section 2). There was a slightly less
pronounced e¡ect in the zinc-loaded protein than
there was with AFP in the absence of Zn2. KSV
was 6.14 þ 0.08 M31 when no zinc was present,
whereas KSV = 5.82 þ 0.05 and 5.35 þ 0.07 M31 for
[Zn2]/[AFP] = 1.0 and 10, respectively. This sug-
gests that the accessibility of Trp decreases as zinc
binds to the protein. In Fig. 4, we present near (A)
and far UV CD spectra of AFP (B) with di¡erent
zinc concentrations. It can be seen that addition of
Zn2 to AFP solutions induces only minor changes
in the near UV CD spectrum. This indicates that the
degree of asymmetry of the environment of aro-
matic amino acid residues is essentially unaltered
by zinc coordination. The absence of changes in
Table 1
Results from RaSP analysis of AFP and serum albumin
Structure CD IR IRCD hybrid
AFP BSA SECV AFP BSA SECV AFP BSA SECV
K-helix 53.1 69.8 8.1 64.4 48.7 8.5 60.4 61.5 6.7
L-sheet 6.2 0 11.6 0 2.4 7.7 0 0 7.9
Turn 11.3 10.9 4.5 13.7 14.3 4.1 11.3 10.9 4.4
Remainder 29.1 30.5 9.8 30.6 37.2 11.1 30.9 30.7 9.6
Values in the table represent the percentage of each structure found by the analysis.
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the far UV CD spectra of AFP (Fig. 4B) shows that
secondary structure of AFP is not changed by zinc
binding.
These results are supported by the FTIR spectra of
zinc-free and zinc-loaded AFP. Fig. 5 shows that
only subtle changes were induced in the infrared
spectrum of AFP by complexation with ZnCl2. In
particular, a reproducible narrowing of the amide I
and II bands was observed which is indicative of
either a slight increase (95%) in the amount of K-
helix in the protein or possibly a decrease in the
conformational sampling of the protein, i.e., an in-
crease in rigidity. A subtle narrowing was also ob-
served in the IR spectrum of BSA in the presence of
ZnCl2, which is consistent with the well-known sim-
ilarity of these two proteins (Fig. 5).
In contrast to this similarity, a prominent new
band appeared at 1592 cm31 with AFP in the pres-
ence of ZnCl2. As shown in Fig. 5, the band clearly
does not arise from zinc chloride alone. To identify
the group responsible for the band, ATR-FTIR spec-
tra of several amino acids were collected (Fig. 5) in
the presence and absence of an excess of ZnCl2. Of
these, only aspartic acid exhibited a ZnCl2-induced
band that matched the frequency observed in the
protein spectrum. This allows us to hypothesize
that aspartate residues are involved in the coordina-
Fig. 3. Stern^Volmer plots for acrylamide quenching of AFP
tryptophan £uorescence under conditions of di¡erent excess of
Zn2 : no zinc added (a), [Zn2]/[AFP] = 1.0 (P) and [Zn2]/
[AFP] = 10 (E). Measurements were carried out in 10 mM
HEPES bu¡er (pH 8.0) at 25‡C. Protein concentration was
kept around 0.01 mg/ml.
Fig. 2. Spectro£uorometric Zn2-titration of AFP monitored by
changes in intrinsic £uorescence intensity at 360 nm (A) or £uo-
rescence intensity of bis-ANS at 440 nm (B). Open and closed
symbols in A correspond to the AFP titration by ZnCl2 and
ZnSO4, respectively. Solid lines in both panels represent ¢ts of
the experimental data according to Scheme 1 (see text). The ¢ts
were optimized by varying the number of zinc cations bound,
n, and the binding constant values k1 and k2. The best ¢t was
achieved when k1 = 1.0U109 M31, k2 = 1.1U105 M31 (n = 4.1)
and k1 = 0.9U109 M31, k2 = 1.1U105 M31 (n = 2.5) for the in-
trinsic £uorescence intensity and bis-ANS £uorescence intensity,
respectively. Insets represent corresponding spectra measured in
the absence (solid lines) or in the presence (dashed lines) of
Zn2 ([Zn2]/[Protein] = 10:1). Trp and bis-ANS £uorescence
was excited at 296 or 350 nm, respectively. Measurements were
carried out in 10 mM HEPES bu¡er (pH 8.0) at 25‡C. Protein
concentration was 0.01 mg/ml, whereas bis-ANS concentration
was 0.1 WM.
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tion of zinc. However, we cannot exclude that His
residues also contribute to Zn2 binding, as there is
some enhancement in the intensity of the band with
frequency V1590 cm31 (see Fig. 5).
3.4. Conformational stability of Zn2+-free and Zn2+-
loaded AFP
Results of the conformational stability analysis are
presented in Fig. 6. Calorimetric curves were mea-
sured for zinc-free and zinc-loaded AFP ([Zn2]/
[AFP] = 1.0 and 10). It can be seen that stability of
the protein is not signi¢cantly a¡ected by the ¢lling
Fig. 5. E¡ect of zinc binding on FTIR spectra of AFP, BSA
and several individual amino acid residues (Asp, Glu, His and
Gly). Spectra of zinc-free and zinc-loaded samples are shown
by dashed and solid lines, respectively. See Section 2 for details
of experiments.
Fig. 4. E¡ect of zinc binding on near (A) and far UV CD spec-
tra of AFP (B). Spectra were collected under conditions of dif-
ferent excess of Zn2 : no zinc added (solid lines), [Zn2]/
[AFP] = 1.0 (dotted lines) and [Zn2]/[AFP] = 10 (dashed lines).
Protein concentration was 0.5 and 1.0 mg/ml whereas cell path-
length was 10 and 0.1 mm for near and far UV CD spectra
measurements, respectively.
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of the strong zinc-binding site ([Zn2]/[AFP] = 1.0),
whereas the binding of additional zinc ions causes
some decrease in protein stability. The data pre-
sented in Fig. 6 show that the Tm of AFP is shifted
downward by V2‡C when a 10-fold molar excess of
zinc is present.
It is known that chloride ion may destabilize the
protein structure [48]. To exclude this possibility,
AFP thermal stability in the presence of 150 mM
NaCl was studied. Fig. 6 shows that the addition
of large excess of this anion ([Cl3]/[AFP] = 10 000)
was not accompanied by any detectable changes in
the AFP thermal stability, underlining the destabili-
zation role of Zn2 binding.
4. Discussion
The data obtained in this study show that AFP
has a structure similar to SA and at least ¢ve strong
zinc-binding sites. One of these is characterized by a
dissociation constant KdV1039 M, whereas four
others have a lower a⁄nity (KdV1035 M). Earlier
gel-¢ltration [36] data suggested that AFP has four
to ¢ve high-a⁄nity zinc-binding sites with a dissoci-
ation constant of Kd = 6^8U1036 M. These binding
parameters are similar to those measured here for
the weaker sites (n = 4, Kd = 10U1036 M). However,
we were able to identify a previously undetected very
strong zinc binding site (KdV1039 M) using £uores-
cent titration. The advantage of this technique lies in
its sensitivity to changes in the spectral properties of
the protein or £uorescent dye induced by ligand
binding. More importantly, it allows extraction the
reliable information on very strong interactions if
the binding of ligand to the protein reproducibly
induces changes in the protein £uorescence parame-
ters [49].
In addition, the application of FTIR has allowed
us to extract information on residues that may be
involved in the strong binding of zinc to AFP. Com-
parison of FTIR spectra for bound and unbound
AFP reveals a new band at 1592 cm31 that results
from zinc coordination by side chains. Comparison
of this change with IR spectra of model compounds
has allowed us to tentatively identify the group(s)
responsible for this new band. We have established
that the FTIR spectrum of zinc-loaded aspartate has
a new band at the frequency observed in the spec-
trum of zinc-bound AFP. Additionally, some en-
hancement of the band in the vicinity of 1590 cm31
has been observed for zinc-loaded histidine (see Fig.
5). Thus, aspartate (and, probably, histidines) may
be responsible for the strong coordination of zinc
by AFP. In spite of the strong similarity between
the amide I and II spectra of these proteins, the
same band was not observed in the FTIR spectrum
of zinc-loaded BSA, even in the presence of a 130-
fold excess of ZnCl2. It was shown previously that
the pK of zinc binding to both AFP and HSA is
close to pH 6.0 [36]. This suggests that histidine is
involved in zinc binding, since the pK of imidazole is
close to neutral [50]. Taken together, all this evidence
shows that there is considerable di¡erence in zinc
binding by two homologous proteins, AFP and SA.
Although histidines are crucial for the binding of
zinc by both proteins, aspartate may play an addi-
tional important role in the coordination of Zn2 by
AFP.
Finally, we have shown here that zinc binding to
AFP does not induce signi¢cant changes in protein
structure or stability. Both the FTIR and CD spec-
tra of AFP indicate that this protein is a member of
Fig. 6. Calorimetric curves for zinc-free and zinc-loaded AFP.
Measurements were done under conditions of di¡erent excess of
Zn2 : no zinc added (solid lines), [Zn2]/[AFP] = 1.0 (dotted
lines) and [Zn2]/[AFP] = 10 (dashed lines). Measurements were
carried out in 50 mM cacodylate bu¡er, pH 6.88. Protein con-
centration was 1 mg/ml. Open circles correspond to the AFP
melting in 50 mM cacodylate bu¡er (pH 7.0) in the presence of
150 mM NaCl.
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the all K class. Partial least-squares analysis with the
RaSP reference set [43,44] suggests that the protein
has 60% þ 7 K-helix, no L-sheet, and that its second-
ary structure is not signi¢cantly altered by zinc
binding. As it follows from intrinsic £uorescence
and near UV CD analysis, there are only minor
changes in the environment and solvent accessibility
of the sole Trp residue caused by zinc binding. In
addition, the overall hydrophobicity of AFP in-
creases slightly as a result of zinc binding. This con-
clusion follows from small zinc-induced increase in
bis-ANS £uorescence intensity (inset to Fig. 2B).
Calorimetric analysis shows that the stability of
the protein is also almost insensitive to Zn2 bind-
ing.
These data show that the properties of AFP di¡er
considerably from those of most ligand binding pro-
teins. The e¡ects of natural ligands on the structural
properties and conformational stability of globular
proteins have been categorized [47]. It was concluded
that according to the structural consequences of the
ligand release, ligand-binding proteins could be di-
vided into several classes [47].
Class I : release of ligands does not result in no-
ticeable changes of the unique protein structure,
but the conformational stability of the protein
molecule changes essentially;
Class II : detectable changes of the spatial protein
structure are observed in the ligand-free form ^
however, the protein yet possesses a pronounced
tertiary structure;
Class III : in the ligand-free form the tertiary
structure completely disappears, the secondary
structure is retained, and the protein molecule
remains compact;
Class IV : the ligand-free form of the protein has
no tertiary structure, the secondary structure con-
tent is noticeably less than in the holo-protein,
and dimensions of the apo-protein distinctly di¡er
both from coil dimensions and from that of holo-
protein;
Class V : the apo-form represents a virtually com-
pletely unfolded polypeptide chain.
It was also shown that although the range of pos-
sible structural transformations induced in a protein
molecule by ligand binding is very wide, a change of
global structural properties and/or conformational
stability of the proteins are always observed upon
ligand binding.
Surprisingly, this is not the case for AFP. Thus
this protein represents new class of ligand-binding
proteins, for which neither the global structure nor
the conformational stability are a¡ected by the very
tight binding of the ligand.
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